Bayer has begun construction on a new €50 million pharmaceutical facility in the Beijing Economic-Technological Development Area, aimed at boosting annual output in the...

In another round of litigation loosely or tightly tied to acquisitions, Bayer said it will pay $1.6 billion to settle with US plaintiffs alleging that its now...

Bayer is to acquire UK biotech Kandy Therapeutics in a move that will expand its drug development pipeline in women’s healthcare.

In the ongoing litigation over whether Monsanto’s Roundup herbicide causes cancer, Bayer has suffered another setback, losing its appeal of the first of three US jury...

Bayer has backed away from plans to create a science advisory panel to help decide still outstanding claims from US plaintiffs that Monsanto’s glyphosate-based herbicide...

Bayer’s relief over its recent deal to settle three-quarters of its outstanding Roundup-related US lawsuits for more than $10 billion altogether could be short-lived.

After nearly a year of deliberation, Bayer has clinched a deal to settle three-quarters of its outstanding lawsuits from US plaintiffs who claim that Monsanto’s top...

Bayer has halted work on a $1 billion production facility for the herbicide active ingredient dicamba in the US state of Louisana but said the decision was not related...